Canine Immune Mediated Thrombocytopenia

Research output: Contribution to journalJournal Article

Abstract

Immune-mediated thrombocytopenia (IMT) is a common disease in dogs. Primary IMT is idiopathic, while secondary IMT can result from a variety of infectious agents or some treatments. Symptoms may include lethargy, anorexia and mild pyrexia, together with a low platelet count and associated bleeding disorders. Prognosis is generally positive, but reduced with presence of melena or raised blood urea nitrogen. Treatment will include some form of immunosuppressive therapy, such as prednisolone, which can have multiple side effects. Nursing the IMT patient will aim at monitoring and reducing spontaneous haemorrhage and managing treatment side effects. To ensure owner understanding and compliance, it is vital to discuss these side effects and any appropriate home adjustments so an achievable plan can be developed for home care.
Original languageEnglish
Pages (from-to)264-269
Number of pages6
JournalThe Veterinary Nurse
Volume10
Issue number5
Early online date21 Jun 2019
DOIs
Publication statusPublished - Jun 2019

Fingerprint

Idiopathic Thrombocytopenic Purpura
Canidae
Hemorrhage
Dog Diseases
Melena
Social Adjustment
Lethargy
Blood Urea Nitrogen
Anorexia
Therapeutics
Immunosuppressive Agents
Home Care Services
Prednisolone
Platelet Count
Compliance
Nursing
Fever

Keywords

  • canine immune-mediated thrombocytopenia
  • platelet count
  • veterinary nursing
  • immunosuppressive therapy

Cite this

@article{50626d4c5ce14e65b5c510ecf415ee80,
title = "Canine Immune Mediated Thrombocytopenia",
abstract = "Immune-mediated thrombocytopenia (IMT) is a common disease in dogs. Primary IMT is idiopathic, while secondary IMT can result from a variety of infectious agents or some treatments. Symptoms may include lethargy, anorexia and mild pyrexia, together with a low platelet count and associated bleeding disorders. Prognosis is generally positive, but reduced with presence of melena or raised blood urea nitrogen. Treatment will include some form of immunosuppressive therapy, such as prednisolone, which can have multiple side effects. Nursing the IMT patient will aim at monitoring and reducing spontaneous haemorrhage and managing treatment side effects. To ensure owner understanding and compliance, it is vital to discuss these side effects and any appropriate home adjustments so an achievable plan can be developed for home care.",
keywords = "canine immune-mediated thrombocytopenia, platelet count, veterinary nursing, immunosuppressive therapy",
author = "Susan Holt and Isabell Riley",
year = "2019",
month = "6",
doi = "10.12968/vetn.2019.10.5.264",
language = "English",
volume = "10",
pages = "264--269",
journal = "The Veterinary Nurse",
issn = "2044-0065",
publisher = "Mark Allen Group",
number = "5",

}

Canine Immune Mediated Thrombocytopenia. / Holt, Susan; Riley, Isabell.

In: The Veterinary Nurse, Vol. 10, No. 5, 06.2019, p. 264-269.

Research output: Contribution to journalJournal Article

TY - JOUR

T1 - Canine Immune Mediated Thrombocytopenia

AU - Holt, Susan

AU - Riley, Isabell

PY - 2019/6

Y1 - 2019/6

N2 - Immune-mediated thrombocytopenia (IMT) is a common disease in dogs. Primary IMT is idiopathic, while secondary IMT can result from a variety of infectious agents or some treatments. Symptoms may include lethargy, anorexia and mild pyrexia, together with a low platelet count and associated bleeding disorders. Prognosis is generally positive, but reduced with presence of melena or raised blood urea nitrogen. Treatment will include some form of immunosuppressive therapy, such as prednisolone, which can have multiple side effects. Nursing the IMT patient will aim at monitoring and reducing spontaneous haemorrhage and managing treatment side effects. To ensure owner understanding and compliance, it is vital to discuss these side effects and any appropriate home adjustments so an achievable plan can be developed for home care.

AB - Immune-mediated thrombocytopenia (IMT) is a common disease in dogs. Primary IMT is idiopathic, while secondary IMT can result from a variety of infectious agents or some treatments. Symptoms may include lethargy, anorexia and mild pyrexia, together with a low platelet count and associated bleeding disorders. Prognosis is generally positive, but reduced with presence of melena or raised blood urea nitrogen. Treatment will include some form of immunosuppressive therapy, such as prednisolone, which can have multiple side effects. Nursing the IMT patient will aim at monitoring and reducing spontaneous haemorrhage and managing treatment side effects. To ensure owner understanding and compliance, it is vital to discuss these side effects and any appropriate home adjustments so an achievable plan can be developed for home care.

KW - canine immune-mediated thrombocytopenia

KW - platelet count

KW - veterinary nursing

KW - immunosuppressive therapy

U2 - 10.12968/vetn.2019.10.5.264

DO - 10.12968/vetn.2019.10.5.264

M3 - Journal Article

VL - 10

SP - 264

EP - 269

JO - The Veterinary Nurse

JF - The Veterinary Nurse

SN - 2044-0065

IS - 5

ER -